GE HealthCare Technologies Inc.

NasdaqGS:GEHC Stock Report

Market Cap: US$38.7b

GE HealthCare Technologies Future Growth

Future criteria checks 1/6

GE HealthCare Technologies is forecast to grow earnings and revenue by 11.5% and 4.2% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 17.4% in 3 years.

Key information

11.5%

Earnings growth rate

11.9%

EPS growth rate

Medical Equipment earnings growth16.6%
Revenue growth rate4.2%
Future return on equity17.4%
Analyst coverage

Good

Last updated17 Jan 2025

Recent future growth updates

Recent updates

GE HealthCare Technologies Is A Speculative Buy (Technical Analysis)

Jan 16

An Intrinsic Calculation For GE HealthCare Technologies Inc. (NASDAQ:GEHC) Suggests It's 37% Undervalued

Jan 03
An Intrinsic Calculation For GE HealthCare Technologies Inc. (NASDAQ:GEHC) Suggests It's 37% Undervalued

2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens

Dec 19

With GE HealthCare Technologies Inc. (NASDAQ:GEHC) It Looks Like You'll Get What You Pay For

Dec 16
With GE HealthCare Technologies Inc. (NASDAQ:GEHC) It Looks Like You'll Get What You Pay For

GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher

Dec 06

From Spin-Off To Standout: GE HealthCare Is Pretty Impressive

Oct 30

GE HealthCare: The Image Of More Upside Is Very Real

Sep 18

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

Sep 05
Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

GE HealthCare Q2 Earnings Recap (Rating Downgrade)

Aug 06

GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities

Jul 07

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

May 21
Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

May 02

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25
GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies' Roar Higher Isn't Over Yet

Mar 09

Earnings and Revenue Growth Forecasts

NasdaqGS:GEHC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202722,3432,5412,4673,0725
12/31/202621,4572,3142,3372,91018
12/31/202520,4702,0492,2052,55720
12/31/202419,6861,8671,8302,25718
9/30/202419,5591,6751,6952,088N/A
6/30/202419,5181,5841,6172,000N/A
3/31/202419,4951,5741,6632,052N/A
12/31/202319,5521,3891,7142,101N/A
9/30/202319,2841,5341,7232,093N/A
6/30/202319,0381,6431,7012,065N/A
3/31/202318,7051,6981,7602,113N/A
12/31/202218,3411,8981,8032,113N/A
9/30/202217,9921,9147541,060N/A
6/30/202217,7201,9297241,016N/A
3/31/202217,5822,0371,2651,555N/A
12/31/202117,5852,2291,3591,607N/A
12/31/202017,1642,0071,4281,687N/A
12/31/201916,6331,6521,6581,989N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GEHC's forecast earnings growth (11.5% per year) is above the savings rate (2.6%).

Earnings vs Market: GEHC's earnings (11.5% per year) are forecast to grow slower than the US market (14.9% per year).

High Growth Earnings: GEHC's earnings are forecast to grow, but not significantly.

Revenue vs Market: GEHC's revenue (4.2% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: GEHC's revenue (4.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: GEHC's Return on Equity is forecast to be low in 3 years time (17.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 23:10
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GE HealthCare Technologies Inc. is covered by 28 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Navann Ty DietschiBNP Paribas Exane
Craig BijouBofA Global Research
Michael GormanBTIG